AriBio Co., Ltd.   Report issue

For profit Phase 2
Founded: Seoul Korea, Republic of (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2018
NCT03625622
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

AriBio Co., Ltd.